These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34370872)

  • 1. Chronic spontaneous urticaria in the United States: patient characteristics and treatment patterns.
    Pourali SP; Gutierrez Y; Kucharik AH; Rajkumar JR; Jones ME; Armstrong AW
    Int J Dermatol; 2022 Aug; 61(8):e308-e309. PubMed ID: 34370872
    [No Abstract]   [Full Text] [Related]  

  • 2. Omalizumab is effective in patients with chronic spontaneous urticaria plus multiple chronic inducible urticaria.
    Skander D; Allenova A; Maurer M; Kolkhir P
    Eur Ann Allergy Clin Immunol; 2021 Mar; 53(2):91-93. PubMed ID: 32496030
    [No Abstract]   [Full Text] [Related]  

  • 3. Chronic Urticaria.
    Hsu JI; Hsu S
    Skinmed; 2022; 20(4):364-366. PubMed ID: 36314621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic Urticaria.
    Hsu JI; Hsu S
    Skinmed; 2022; 20(5):364-366. PubMed ID: 36314703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of clinical factors as possible predictors of response to omalizumab and relapse after treatment discontinuation in chronic spontaneous urticaria.
    Foti C; Romita P; Ambrogio F; Fanelli M; Panebianco R; Vena GA; Cassano N; Ragusa M; Giuffrida R; Papaianni V; Borgia F; Cannavò SP; Guarneri F
    Dermatol Ther; 2022 Feb; 35(2):e15248. PubMed ID: 34877757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omalizumab serum levels predict treatment outcomes in patients with chronic spontaneous urticaria: A three-month prospective study.
    Ghazanfar MN; Bartko EA; Arildsen NS; Poulsen LK; Jensen BM; Enevold C; Holm JG; Woetmann A; Ødum N; Thomsen SF
    Clin Exp Allergy; 2022 May; 52(5):715-718. PubMed ID: 35278253
    [No Abstract]   [Full Text] [Related]  

  • 7. New markers to predict the response to omalizumab in chronic spontaneous urticaria.
    Coşansu NC; Kara RÖ; Yaldiz M; Dikicier BS
    Dermatol Ther; 2022 Aug; 35(8):e15589. PubMed ID: 35582853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of omalizumab in Chinese patients with anti-histamine refractory chronic spontaneous urticaria.
    Yuan W; Hu S; Li M; Yang L; Liu L; Zheng M; Guo Z; Song Z; Zhang C; Diao Q; Xu J; Richard A; Patwardhan M; Lyu T; Uddin A; Fogel R; Ligueros-Saylan M; Zheng J
    Dermatol Ther; 2022 Apr; 35(4):e15303. PubMed ID: 34984792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-TPO IgG/Total IgE Ratio: Biomarker for Omalizumab Response Prediction in Chronic Spontaneous Urticaria.
    Brás R; Esteves Caldeira L; Bernardino A; Costa C
    Int Arch Allergy Immunol; 2023; 184(9):866-869. PubMed ID: 37557083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indication of Omalizumab for Chronic Urticaria Using the 'Urticaria Control Test' Instead of 'Urticaria Activity Score': Possible Impact for Health Systems.
    Sánchez J; Alvarez L; López JF
    Actas Dermosifiliogr; 2024 Jan; 115(1):88-90. PubMed ID: 36754254
    [No Abstract]   [Full Text] [Related]  

  • 11. Indication of Omalizumab for Chronic Urticaria Using the 'Urticaria Control Test' Instead of 'Urticaria Activity Score': Possible Impact for Health Systems.
    Sánchez J; Alvarez L; López JF
    Actas Dermosifiliogr; 2024 Jan; 115(1):T88-T90. PubMed ID: 37871896
    [No Abstract]   [Full Text] [Related]  

  • 12. Positive basophil histamine release assay predicts insufficient response to standard-dosed omalizumab in patients with chronic spontaneous urticaria.
    Baumann K; Jørgensen AR; Sørensen JA; Zhang DG; Ghazanfar MN; Skov PS; Woetmann A; Vestergaard C; Maurer M; Thomsen SF
    Clin Exp Allergy; 2023 Dec; 53(12):1318-1321. PubMed ID: 37771063
    [No Abstract]   [Full Text] [Related]  

  • 13. Delayed Pressure Urticaria: Clinical and Diagnostic Features and Response to Omalizumab.
    Veleiro-Pérez B; Alba-Muñoz J; Pérez-Quintero O; Rodríguez RL; Calvín-Lamas M; Parra-Arrondo A
    Int Arch Allergy Immunol; 2022; 183(10):1089-1094. PubMed ID: 35609554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical variables of severe chronic spontaneous urticaria from total IgE standpoint: a retrospective study.
    Asero R
    Eur Ann Allergy Clin Immunol; 2022 Jan; 54(1):30-33. PubMed ID: 33555151
    [No Abstract]   [Full Text] [Related]  

  • 15. Biomarkers for Monitoring Treatment Response of Omalizumab in Patients with Chronic Urticaria.
    Pedersen NH; Sørensen JA; Ghazanfar MN; Zhang DG; Vestergaard C; Thomsen SF
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Definition of Recurrent Chronic Spontaneous Urticaria.
    Melé-Ninot G; Serra-Baldrich E; Curto-Barredo L; Figueras-Nart I; Spertino J; Expósito-Serrano V; García-Navarro X; Guilabert A; Bielsa-Marsol I; Giménez-Arnau AM
    Acta Derm Venereol; 2020 Sep; 100(16):adv00267. PubMed ID: 32926176
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of the Patients with Chronic Urticaria Who Responded and Did Not Respond to Omalizumab Treatment: A Single-Center Retrospective Study.
    Cakmak ME
    Int Arch Allergy Immunol; 2022; 183(11):1209-1215. PubMed ID: 36007494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic spontaneous urticaria treated with omalizumab: what differentiates early from late responders?
    Asero R
    Eur Ann Allergy Clin Immunol; 2021 Jan; 53(1):47-48. PubMed ID: 32378398
    [No Abstract]   [Full Text] [Related]  

  • 19. Does synthetic pharmacotherapy still have a place in treating chronic spontaneous urticaria?
    Thiede RM; Fazel M; MacDonald KM; Abraham I
    Expert Opin Pharmacother; 2022 Oct; 23(14):1563-1567. PubMed ID: 36173375
    [No Abstract]   [Full Text] [Related]  

  • 20. Drugs in Development for Chronic Spontaneous Urticaria.
    Nguyen W; Liu W; Yamauchi P
    J Drugs Dermatol; 2023 Apr; 22(4):393-397. PubMed ID: 37026883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.